CV | Twitter | LinkedIn | ResearchGate | ORCID | Operation Naloxone


Lucas Hill earned his Doctor of Pharmacy degree from the University of Missouri–Kansas City School of Pharmacy before completing a pharmacy residency and faculty development fellowship in the University of Pittsburgh Medical Center Department of Family Medicine. Dr. Hill is now a clinical assistant professor of health outcomes and pharmacy practice at The University of Texas at Austin College of Pharmacy. He precepts learners and provides comprehensive medication management services for patients with complex chronic diseases at the CommUnityCare Southeast Health & Wellness Center. In 2017, Dr. Hill was recognized for excellence in clinical education with the William Arlyn Kloesel Outstanding Preceptor Award.

Dr. Hill is Director of Operation Naloxone, an interprofessional collaborative that provides overdose prevention training and resources to health professionals, educational institutions, and the public. He is the principal investigator for the Texas Targeted Opioid Response: Overdose Prevention Project and directs more than one million dollars in funding to combat the opioid crisis. Dr. Hill co-coordinates the Foundations for Interprofessional Collaborative Practice course established by UT Pharmacy, Nursing, Social Work, and Medicine. He is Faculty Advisor of the Student Pharmacist Recovery Network, Social Media Editor of iForumRx, a board member of the Austin Harm Reduction Coalition, and an affiliate of the Center for Health Communication.

Media & Publications

The Daily Texan | Trump Declares Opioid Crisis a Public Health Emergency

The Daily Texan | Center for Health Communication Receives Contract to Promote Texas’ Prescription Monitoring Program

Han JK, Hill LG, Koenig ME, Das N. Naloxone Counseling for Harm Reduction and Patient Engagement. Fam Med. 2017;49(9):730-3.

UT News | This is Why the Opioid Crisis is as Dangerous as a Terrorist Attack

The Utopian | Minimizing Harm

NPR Marketplace | Overdose Prevention on College Campuses

The Daily Texan | Brave New Book Advertises Kratom Drug for Sale

Corbo JM, Delellis TM, Hill LG, Rindfuss SL. ACE inhibitors or ARBs to prevent CKD in patients with microalbuminuriaAm Fam Physician. 2016;94(8):652-3.

iForumRx Commentary | Coprescribing Naloxone: A Moral Imperative

iForumRx Podcast | Opioid Safety & Overdose Prevention (iTunes / PodBean)

iForumRx Resource Page | Opioid Safety & Overdose Prevention

The Daily Texan | College of Pharmacy Combats Opioid Overdose with Campus Campaign

2409 University Avenue | A1910, PHR 2.222G | Austin, TX 78712 | 512.232.7832 |